Day: September 6, 2023
WATERTOWN, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), today announced that Maria Palasis, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences in September:H.C. Wainwright 25th Annual Global Investment Conference – Fireside chat on Wednesday, September 13th at 2:00 p.m. ET
Cantor Global Healthcare Conference 2023 – Fireside chat on Tuesday, September 26th at 4:20 p.m. ETLive webcast of the presentations will be available on the Investor Relations section of the Company’s website at investors.lyratherapeutics.com. Replays of the webcasts will be available for 30 days following the presentation.
About Lyra...
Verizon Chairman & CEO to speak at Goldman Sachs conference September 7
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — Hans Vestberg, Chairman and CEO of Verizon (NYSE, Nasdaq: VZ), is scheduled to speak at the Goldman Sachs Communacopia + Technology Conference on Thursday, September 7, at 11:10 a.m. ET. His remarks will be webcast, with access instructions available on Verizon’s Investor Relations website, www.verizon.com/about/investors/.
Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed on June 30, 2000 and is one of the world’s leading providers of technology and communications services. Headquartered in New York City and with a presence around the world, Verizon generated revenues of $136.8 billion in 2022. The company offers data, video and voice services and solutions on its award-winning networks and platforms, delivering on customers’ demand for mobility, reliable network connectivity,...
Elicio Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Written by Customer Service on . Posted in Public Companies.
BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that Robert Connelly, Chief Executive Officer, will present at the upcoming H.C. Wainwright 25th Annual Global Investment Conference on September 13, 2023 at 9:30 a.m. ET.
A live webcast of the presentation will be accessible to registered attendees via the company’s Events page. An archived replay will be available on-demand for 30 days following the event.
About Elicio Therapeutics
Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer. By combining expertise in immunology and immunotherapy, Elicio is...
Barrett Mooney, AgEagle Chairman and CEO, Featured on Varney & Co. on FOX Business News
Written by Customer Service on . Posted in Public Companies.
AgEagle Aerial Systems, Inc.AgEagle Chairman and CEO, Featured on Varney & Co. on FOX Business NewsWICHITA, Kan., Sept. 06, 2023 (GLOBE NEWSWIRE) — Barrett Mooney, Chairman and CEO of AgEagle Aerial Systems Inc. (NYSE American: UAVS) (“AgEagle” or the “Company”), an industry-leading provider of full stack flight hardware, sensors and software for commercial and government use, was interviewed live yesterday morning on FOX Business Network’s Varney & Co., hosted by British American economic and political commentator Stuart Varney.
Broadcast live from the floor of the Exhibit Hall at the Commercial UAV Expo in Las Vegas and aired nationally on the FOX Business Channel, Mooney discussed the reasons why AgEagle’s new eBee™ VISION drone, the next generation in Intelligence, Surveillance and Reconnaissance...
Danforth Advisors Extends Variable Resource Model to Preclinical and Clinical Development; Acquires Elite BioPharma Consulting to Add Clinical Development Operations to Range of Capabilities
Written by Customer Service on . Posted in Mergers And Acquisitions.
WALTHAM, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Danforth Advisors, LLC, today announced the acquisition of Elite BioPharma Consulting, Inc., broadening the range of its newly formed Development Strategy and Operations (DS&O) practice and supporting life science companies in the advancement of preclinical and clinical programs without the burden of fixed costs. With the acquisition of Elite, Danforth becomes the single provider of enterprise-wide managed functions – from corporate to clinical – tailored to support life science companies at all stages of development.
The Elite acquisition adds the following capabilities to Danforth’s DS&O practice.Clinical Development Operations
Clinical Project & Trial Management
Clinical Monitoring
Program Management
Regulatory Affairs
Medical WritingFounders Jill C. Bossi,...
Web3 Ventures Expands Portfolio With Acquisition of Unstoppable Domains Shares From Pluto 11.11, Announces Changes to Board of Directors, Announces Amendment of Its Existing Equity Incentive Plan, and Issues Options and Restricted Share Units to Eligible Persons Pursuant to Its Equity Incentive Plan
Written by Customer Service on . Posted in Mergers And Acquisitions.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN
TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) — Web3 Ventures (the “Company”) is excited to announce its recent acquisition of 24,084 Series A-1 Preferred Stock of Unstoppable Domains Inc. (“Unstoppable Domains”) from Pluto 11.11 Inc. (“Pluto”) value of USD $1,110,978.07 in exchange for 302,186 multiple voting shares (“MVS Shares”) in the capital of the Company valued at CAD$5.00 each (the “Transaction”).
Terms of the Transaction
As a condition of the Transaction, the Company entered into several agreements with Unstoppable Domains and its existing shareholders, including a Voting Agreement, ROFR and Co-Sale Agreement, Investors’ Rights Agreement, and Token Agreement.
Unstoppable...
Check Point to Acquire Atmosec, an Innovative SaaS Security Vendor, as part of its Strategy to Deliver the Most Secure SASE Solution
Written by Customer Service on . Posted in Mergers And Acquisitions.
The technology will allow organizations to prevent cyberattacks on their SaaS ecosystem: discover and disconnect malicious applications, prevent communication with risky 3rd party applications and fix SaaS misconfigurations
SAN CARLOS, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, has announced the acquisition of Atmosec. An early-stage start-up, Atmosec specializes in the rapid discovery and disconnection of malicious SaaS applications, preventing risky 3rd party SaaS communications, and rectifying SaaS misconfigurations. The move reinforces Check Point‘s commitment to enhance its SaaS security offering and address the security gaps and blind spots in SaaS applications. Atmosec was founded in January 2021 and employs 17...
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
Written by Customer Service on . Posted in Mergers And Acquisitions.
Merger with Notable expected to close in mid-October, subject to shareholder approval
Special shareholder meeting scheduled for October 12, 2023
MODI’IN, Israel and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced that its registration statement on Form S-4 in connection with the proposed merger with Notable Labs, Inc. (“Notable”) has been declared effective by the U.S. Securities and Exchange Commission (“SEC”).
The definitive merger agreement between VBL and Notable was announced on February 23, 2023 and is expected to close in mid-October 2023, subject to customary closing conditions, including approval of the merger by VBL’s shareholders. The registration statement contains a proxy statement / prospectus / information statement in connection with the merger. A copy of the...
Whitestone REIT Declares Fourth Quarter 2023 Dividend
Written by Customer Service on . Posted in Dividend Reports And Estimates.
HOUSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a monthly cash dividend of $0.04 per share on the Company’s common shares and operating partnership units for the fourth quarter of 2023. The dividend increase represents a quarterly amount of $0.12 per share, and an annualized amount of $0.48 per share.
“At Whitestone, we are successfully executing on our growth strategy and continue to drive very strong leasing spreads while posting near-record occupancy, as we shared during our 2nd quarter earnings call,” said Dave Holeman, Whitestone’s CEO. “We remain focused on FFO per share growth and simultaneously strengthening our balance sheet.”
The fourth quarter dividend distribution for 2023 will be as detailed below:Month
Record...
Regency Centers to Present at the BofA Securities 2023 Global Real Estate Conference
Written by Customer Service on . Posted in Public Companies.
JACKSONVILLE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency” or the “Company”) (Nasdaq: REG) today announced that Mike Mas, Executive Vice President and Chief Financial Officer, is scheduled to make a presentation at the 2023 BofA Securities 2023 Global Real Estate Conference (the “Conference”) on Wednesday, September 13, 2023, at 2:10 pm ET. To access the Company’s live presentation, use the webcast registration link below.Regency Centers PresentationDate:
Wednesday, September 13, 2023Time:
2:10 p.m. – 2:45 p.m. ETSpeakers:
Mike Mas – Executive Vice President & Chief Financial OfficerChristy McElroy – Senior Vice President, Capital MarketsWebcast Link:
Regency Centers BofA Securities 2023 Global Real Estate Conference
A replay of the webcast will be available on the Company’s...